The latest closing stock price for Ultragenyx Pharmaceutical as of November 20, 2024 is 46.40.
An investor who bought $1,000 worth of Ultragenyx Pharmaceutical stock at the IPO in 2014 would have $98 today, roughly 0 times their original investment - a 0.86% compound annual growth rate over 11 years.
The all-time high Ultragenyx Pharmaceutical stock closing price was 177.39 on December 23, 2020.
The Ultragenyx Pharmaceutical 52-week high stock price is 60.37, which is 30.1% above the current share price.
The Ultragenyx Pharmaceutical 52-week low stock price is 37.02, which is 20.2% below the current share price.
The average Ultragenyx Pharmaceutical stock price for the last 52 weeks is 47.39.
An investor who bought $1,000 worth of Ultragenyx Pharmaceutical stock at the IPO in 2014 would have $98 today, roughly 0 times their original investment - a 0.86% compound annual growth rate over 11 years.
The all-time high Ultragenyx Pharmaceutical stock closing price was 177.39 on December 23, 2020.
The Ultragenyx Pharmaceutical 52-week high stock price is 60.37, which is 30.1% above the current share price.
The Ultragenyx Pharmaceutical 52-week low stock price is 37.02, which is 20.2% below the current share price.
The average Ultragenyx Pharmaceutical stock price for the last 52 weeks is 47.39.